[CME: Primary and Secondary Hypercholesterolemia]

Area of Science:

• Cardiology
• Genetics
• Metabolic Disorders

Background:

• Hypercholesterolemia, characterized by elevated LDL-cholesterol, necessitates distinguishing between primary (genetic) and secondary (acquired) causes.
• Familial hypercholesterolemia (FH) is a prevalent genetic disorder leading to significantly high cholesterol levels from birth.

Purpose of the Study:

• To outline diagnostic considerations for primary hypercholesterolemia (familial hypercholesterolemia) in patients with elevated LDL-cholesterol.
• To emphasize the importance of identifying secondary causes of hypercholesterolemia before initiating lipid-lowering therapy.

Main Methods:

• Clinical diagnosis supported by family history and specific diagnostic findings.
• Utilizing the Lipid Clinic Network Score to estimate the likelihood of familial hypercholesterolemia.
• Evaluating exogenous factors and medical conditions that can lead to secondary hypercholesterolemia.

Main Results:

• Patients with LDL-cholesterol >5 mmol/l should be evaluated for familial hypercholesterolemia.
• Diagnosis of FH is supported by clinical findings, family history, and potentially the Lipid Clinic Network Score.
• Secondary hypercholesterolemia can result from hypothyroidism, cholestasis, nephrotic syndrome, or certain medications.

Conclusions:

• Prompt identification and management of familial hypercholesterolemia are crucial due to its genetic basis and associated cardiovascular risks.
• Screening relatives of FH patients is essential for early detection and intervention.
• Excluding secondary causes of hypercholesterolemia is a critical step prior to suspecting FH or commencing lipid-lowering treatments.